Ion channels are key components in a wide variety of biological processes that involve rapid changes in cells and have broad therapeutic applicability across multiple therapeutic areas including oncology, metabolic disease, pain, neurological diseases, infectious diseases and others. The differentiated core capabilities at Icagen can provide novel reagent generation and proprietary assays that can also support antibody discovery programs and can be accessed by partners when pursuing ion channels and transporter targets, allowing the advancement of drug discovery against this challenging target class.
Ion Channel Technology Platform
Leading the Way for New Drug Discoveries
The differentiated core capabilities at OmniAb, Inc.– Icagen Ion Channel technology can provide novel reagent generation and proprietary assays that can also support antibody discovery programs and can be accessed by partners when targeting ion channels with antibodies, small molecules or other modalities.